Page 86 - Read Online
P. 86

35.                                             62.  Yu J, Shen B, Chu ES, Teoh N, Cheung KF, Wu CW, Wang S, Lam
            55.  Wu P, Dugoua JJ, Eyawo O, Mills EJ. Traditional Chinese medicines   CN, Feng H, Zhao J, Cheng AS, To KF, Chan HL, Sung JJ. Inhibitory
               in the treatment of hepatocellular cancers: a systematic review and   role  of peroxisome  proliferator-activated  receptor  gamma  in
               meta-analysis. J Exp Clin Cancer Res 2009;28:112.  hepatocarcinogenesis in mice and in vitro. Hepatology 2010;51:2008-
            56.  Fu F, Wan Y, Mulati, Wu T. Kanglaite injection combined with hepatic   19.
               arterial  intervention for unresectable  hepatocellular  carcinoma:  a   63.  Giuliano M, Pellerito O, Portanova P, Calvaruso G, Santulli A, De
               meta-analysis. J Cancer Res Ther 2014;10:38-41.    Blasio A, Vento R, Tesoriere G. Apoptosis induced in HepG2 cells
            57.  Vara D, Salazar M, Olea-Herrero N, Guzman M, Velasco G, Diaz-  by the synthetic cannabinoid WIN: involvement of the transcription
               Laviada  I.  Anti-tumoral  action  of cannabinoids on hepatocellular   factor PPARgamma. Biochimie 2009;91:457-65.
               carcinoma: role of AMPK-dependent activation of autophagy. Cell   64.  Jiang M, Fernandez S, Jerome WG, He Y, Yu X, Cai H, Boone B,
               Death Differ 2011;18:1099-111.                     Yi  Y, Magnuson MA,  Roy-Burman P, Matusik RJ,  Shappell SB,
            58.  Velasco G, Sanchez C, Guzman M. Towards the use of cannabinoids   Hayward SW. Disruption of PPARgamma signaling results in mouse
               as antitumour agents. Nat Rev Cancer 2012;12:436-44.  prostatic intraepithelial  neoplasia involving active  autophagy.  Cell
            59.  O’Sullivan  SE. Cannabinoids  go nuclear:  evidence  for  activation   Death Differ 2010;17:469-81.
               of peroxisome proliferator  activated  receptors.  Br J Pharmacol   65.  Vara D, Morell C, Rodrıguez-Henche N, Diaz-Laviada I. Involvement
               2007;152:576-82.                                   of PPARc in the antitumoral action of cannabinoids on hepatocellular
            60.  Yousse FJ, Badr M. Peroxisome proliferator-activated receptors and   carcinoma. Cell Death Dis 2013;4,e618.
               cancer: challenges and opportunities. Br J Pharmacol 2011;164:68-  66.  Salazar M, Hernandez-Tiedra S, Torres S, Lorente M, Guzman M,
               82.                                                Velasco G. Detecting autophagy in response to ER stress signals in
            61.  Shen B, Chu ES, Zhao G, Man K, Wu CW, Cheng JT, Li G, Nie Y,   cancer. Methods Enzymol 2011;489:297-317.
               Lo CM, Teoh N, Farrell GC, Sung JJ, Yu J. PPARgamma inhibits   67.  Takahashi  Y, Ohoka N, Hayashi H, Sato R.  TRB3 suppresses
               hepatocellular  carcinoma metastases  in vitro and in mice.  Br J   adipocyte  differentiation  by negatively  regulating  PPARgamma
               Cancer 2012;106:1486-94.                           transcriptional activity. J Lipid Res 2008;49:880-92.



























































                  Hepatoma Research | Volume 2 | March 9, 2016                                             77
   81   82   83   84   85   86   87   88   89   90   91